Khalafallah, A. A., Fernandopulle, B., & Brain, T. (2010). Dose-modified lenalidomide induces sustained hematological response in patients with intermediate to high risk myelodysplasia. Mediterranean Journal of Hematology and Infectious Diseases, 2(2), e2010012. https://doi.org/10.4084/mjhid.2010.012